Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Lenting

Showing results (71-80 of 170) with videos related to

Pageof 17
Sort By:
Biochimica Et Biophysica Acta|May 22, 2007
Functional duplication of ligand-binding domains within low-density lipoprotein receptor-related protein for interaction with receptor associated protein, alpha2-macroglobulin, factor IXa and factor VIIIAlexander B Meijer, Jakub Rohlena, Carmen van der Zwaan, et al.
Blood|February 22, 2007
Correction of the bleeding time in von Willebrand factor (VWF)-deficient mice using murine VWFPeter J Lenting, Philip G de Groot, Simon F De Meyer, et al.
Thrombosis and Haemostasis|July 18, 2014
Antibody-based prevention of von Willebrand factor degradation mediated by circulatory assist devicesAntoine Rauch, Paulette Legendre, Olivier D Christophe, et al.
Blood|March 5, 2010
Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2BJulie Rayes, Martine J Hollestelle, Paulette Legendre, et al.
Circulation Research|May 26, 2018
von Willebrand Factor for Aortic Valve Intervention: From Bench to Real-Time Bedside AssessmentFlavien Vincent, Antoine Rauch, Valentin Loobuyck, et al.
Plos One|August 27, 2009
Models for prediction of factor VIII half-life in severe haemophiliacs: distinct approaches for blood group O and non-O patientsKathelijn Fischer, Ronan Pendu, Carina J van Schooten, et al.
Blood|June 19, 2008
Macrophages contribute to the cellular uptake of von Willebrand factor and factor VIII in vivoCarina J van Schooten, Shirin Shahbazi, Evelyn Groot, et al.
The Journal of Biological Chemistry|November 14, 2003
An experimental model to study the in vivo survival of von Willebrand factor. Basic aspects and application to the R1205H mutationPeter J Lenting, Erik Westein, Virginie Terraube, et al.
The FEBS Journal|September 27, 2006
Staphylococcus aureus protein A binding to von Willebrand factor A1 domain is mediated by conserved IgG binding regionsMaghnus O'Seaghdha, Carina J van Schooten, Steven W Kerrigan, et al.
Haematologica|July 11, 2019
Correction of bleeding in experimental severe hemophilia A by systemic delivery of factor VIII-encoding mRNAJules Russick, Sandrine Delignat, Peter Milanov, et al.
Pageof 17

Showing results (71-80 of 170) with videos related to

Sort By:
Pageof 17
Biochimica Et Biophysica Acta|May 22, 2007
Functional duplication of ligand-binding domains within low-density lipoprotein receptor-related protein for interaction with receptor associated protein, alpha2-macroglobulin, factor IXa and factor VIIIAlexander B Meijer, Jakub Rohlena, Carmen van der Zwaan, et al.
Blood|February 22, 2007
Correction of the bleeding time in von Willebrand factor (VWF)-deficient mice using murine VWFPeter J Lenting, Philip G de Groot, Simon F De Meyer, et al.
Thrombosis and Haemostasis|July 18, 2014
Antibody-based prevention of von Willebrand factor degradation mediated by circulatory assist devicesAntoine Rauch, Paulette Legendre, Olivier D Christophe, et al.
Blood|March 5, 2010
Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2BJulie Rayes, Martine J Hollestelle, Paulette Legendre, et al.
Circulation Research|May 26, 2018
von Willebrand Factor for Aortic Valve Intervention: From Bench to Real-Time Bedside AssessmentFlavien Vincent, Antoine Rauch, Valentin Loobuyck, et al.
Plos One|August 27, 2009
Models for prediction of factor VIII half-life in severe haemophiliacs: distinct approaches for blood group O and non-O patientsKathelijn Fischer, Ronan Pendu, Carina J van Schooten, et al.
Blood|June 19, 2008
Macrophages contribute to the cellular uptake of von Willebrand factor and factor VIII in vivoCarina J van Schooten, Shirin Shahbazi, Evelyn Groot, et al.
The Journal of Biological Chemistry|November 14, 2003
An experimental model to study the in vivo survival of von Willebrand factor. Basic aspects and application to the R1205H mutationPeter J Lenting, Erik Westein, Virginie Terraube, et al.
The FEBS Journal|September 27, 2006
Staphylococcus aureus protein A binding to von Willebrand factor A1 domain is mediated by conserved IgG binding regionsMaghnus O'Seaghdha, Carina J van Schooten, Steven W Kerrigan, et al.
Haematologica|July 11, 2019
Correction of bleeding in experimental severe hemophilia A by systemic delivery of factor VIII-encoding mRNAJules Russick, Sandrine Delignat, Peter Milanov, et al.
Pageof 17